Therapy with recombinant human antithrombin, heparin and tissue plasminogen activator improves survival and reduces ventilation days in a long-term ovine model of cutaneous burn and smoke inhalation injury
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.